Utah Medical Products, Inc. (UTMD) DCF Valuation

Utah Medical Products, Inc. (UTMD) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Utah Medical Products, Inc. (UTMD) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover the true potential of Utah Medical Products, Inc. (UTMD) with our advanced DCF Calculator! Adjust key assumptions, explore various scenarios, and evaluate how changes affect Utah Medical Products, Inc. (UTMD) valuation – all in one convenient Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 46.9 42.2 49.1 52.3 50.2 51.3 52.5 53.6 54.8 56.0
Revenue Growth, % 0 -10.08 16.3 6.58 -3.93 2.22 2.22 2.22 2.22 2.22
EBITDA 24.5 20.9 26.2 26.9 24.8 26.3 26.9 27.5 28.1 28.7
EBITDA, % 52.26 49.59 53.34 51.4 49.28 51.18 51.18 51.18 51.18 51.18
Depreciation 6.9 7.2 7.3 7.1 6.4 7.5 7.6 7.8 8.0 8.2
Depreciation, % 14.67 17.09 14.85 13.55 12.68 14.57 14.57 14.57 14.57 14.57
EBIT 17.6 13.7 18.9 19.8 18.4 18.8 19.2 19.6 20.1 20.5
EBIT, % 37.59 32.5 38.49 37.85 36.6 36.61 36.61 36.61 36.61 36.61
Total Cash 42.8 51.6 61.0 75.1 92.9 50.4 51.6 52.7 53.9 55.1
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 4.1 5.1 5.5 3.3
Account Receivables, % 0 9.73 10.46 10.59 6.65
Inventories 6.9 6.2 6.6 8.8 9.6 8.1 8.3 8.5 8.6 8.8
Inventories, % 14.74 14.75 13.45 16.86 19.08 15.77 15.77 15.77 15.77 15.77
Accounts Payable 1.1 .8 .8 1.2 .8 1.0 1.0 1.0 1.1 1.1
Accounts Payable, % 2.34 1.87 1.55 2.33 1.53 1.92 1.92 1.92 1.92 1.92
Capital Expenditure -21.5 -.9 -.6 -.8 -.6 -5.3 -5.4 -5.6 -5.7 -5.8
Capital Expenditure, % -45.92 -2.04 -1.13 -1.56 -1.27 -10.38 -10.38 -10.38 -10.38 -10.38
Tax Rate, % 17.19 17.19 17.19 17.19 17.19 17.19 17.19 17.19 17.19 17.19
EBITAT 14.5 10.7 14.6 15.8 15.2 15.1 15.4 15.7 16.1 16.4
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -6.0 13.3 20.0 19.9 21.9 18.4 17.3 17.7 18.1 18.5
WACC, % 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39
PV UFCF
SUM PV UFCF 77.1
Long Term Growth Rate, % 0.50
Free cash flow (T + 1) 19
Terminal Value 380
Present Terminal Value 293
Enterprise Value 370
Net Debt -93
Equity Value 462
Diluted Shares Outstanding, MM 4
Equity Value Per Share 127.12

What You Will Receive

  • Customizable Excel Template: A fully editable Excel-based DCF Calculator featuring pre-filled real UTMD financials.
  • Accurate Data: Historical performance data and forward-looking projections (highlighted in the yellow cells).
  • Assumption Flexibility: Modify forecast parameters such as revenue growth, EBITDA %, and WACC.
  • Instant Calculations: Quickly observe how your inputs influence Utah Medical Products' valuation.
  • Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Interface: Organized for clarity and ease of navigation, complete with step-by-step guidance.

Key Features

  • Customizable Financial Metrics: Adjust essential parameters such as revenue growth, profit margins, and R&D investments.
  • Instant DCF Valuation: Automatically computes intrinsic value, NPV, and other financial metrics with ease.
  • High-Precision Accuracy: Leverages Utah Medical Products, Inc.'s (UTMD) actual financial data for credible valuation results.
  • Effortless Scenario Testing: Evaluate various assumptions and analyze results without complications.
  • Efficiency Booster: Streamline the valuation process and avoid the hassle of constructing intricate models from the ground up.

How It Works

  • 1. Access the Template: Download and open the Excel file containing Utah Medical Products, Inc.'s (UTMD) preloaded data.
  • 2. Modify Assumptions: Adjust key inputs such as growth rates, WACC, and capital expenditures to fit your analysis.
  • 3. Review Results Instantly: The DCF model automatically computes intrinsic value and NPV based on your inputs.
  • 4. Explore Scenarios: Evaluate various forecasts to assess different valuation possibilities.
  • 5. Present with Confidence: Deliver professional valuation insights to enhance your decision-making process.

Why Choose Utah Medical Products, Inc. (UTMD)?

  • Time Efficiency: Quickly access essential medical product insights without extensive research.
  • Enhanced Precision: Dependable data and methodologies minimize inaccuracies in your assessments.
  • Completely Adaptable: Adjust the tools to align with your specific needs and forecasts.
  • User-Friendly: Intuitive interfaces and visual representations simplify the interpretation of results.
  • Endorsed by Professionals: Crafted for industry experts who prioritize accuracy and functionality.

Who Should Use This Product?

  • Investors: Accurately estimate Utah Medical Products, Inc.'s (UTMD) fair value before making investment decisions.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to Utah Medical Products, Inc. (UTMD).
  • Consultants: Quickly adapt the template for valuation reports tailored to clients in the medical sector.
  • Entrepreneurs: Gain insights into financial modeling practices used by leading medical device companies.
  • Educators: Use it as a teaching tool to demonstrate valuation methodologies in the healthcare industry.

What the Template Contains

  • Preloaded UTMD Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.